Dermisonics Inc. (DMSI)

Overview

Dermisonics, Inc. is an innovative company that specializes in the development, manufacturing, and commercialization of advanced drug-delivery technologies. Founded in 2000 and headquartered in Irvine, California, the company has focused its efforts on revolutionizing the way drugs with large molecular structures are administered into the bloodstream. Initially known as Second Stage Ventures, Inc., it underwent a rebranding to Dermisonics, Inc. in October 2004. The key objective behind the inception and ongoing projects of Dermisonics is to provide needle-free delivery solutions, thereby enhancing patient convenience and compliance while minimizing potential discomfort and complications associated with traditional drug administration methods.

Products and Services

Dermisonics, Inc. has pioneered the creation and implementation of ultrasonic transdermal drug-delivery technologies. The cornerstone of its product line is:

• The U-Strip - An active transdermal patch developed by Dermisonics, designed specifically for the needle-free delivery of drugs with large molecular structures directly into the bloodstream. This innovative technology leverages ultrasonic waves to transiently permeate the skin barrier, thereby facilitating the efficient and painless delivery of critical medications, such as Insulin. The U-Strip represents a significant leap forward in drug-delivery technology, aiming to improve patient outcomes through better adherence to medication regimens and reducing the reliance on invasive administration methods.